Health Canada
- Status: approved
remimazolam sedation reversal with flumazenil (remimazolam sedation reversal with flumazenil) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Medical University of Gdansk is the originator. The local marketing authorisation holder may differ — check the official source linked above.